- Exhibit & Support
- Hotel & Travel
Early detection and treatment are critical for prostate cancer—the third-highest cause of cancer-related deaths in men. Recently, PET imaging using PSMA ligands has gained attention as a promising new radiotracer in these patients. Hear from the experts as they discuss implications around this game-changer in prostate cancer treatment.
At the completion of this knowledge-based activity, participants will be able to:
This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.